Literature DB >> 24605795

Following the path of CCL2 from prostaglandins to periostin in lung fibrosis.

Bethany B Moore1.   

Abstract

Without question, the greatest and most humbling honor of my scientific career was to learn that I was nominated for the American Thoracic Society Recognition Award for Scientific Accomplishments. On the occasion of this award, as I look back on the progress made in the last 15 years, I am pleased by the scientific insights; however, I am also saddened that we still have no internationally recognized efficacious therapy. This perspective will highlight the areas my laboratory has addressed regarding the pathogenesis of idiopathic pulmonary fibrosis in hopes of identifying new therapeutic targets.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24605795      PMCID： PMC4068953          DOI： 10.1165/rcmb.2014-0075PS

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN： 1044-1549            Impact factor:   6.914


  88 in total

1.  Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease.

Authors:  Borna Mehrad; Marie D Burdick; David A Zisman; Michael P Keane; John A Belperio; Robert M Strieter
Journal:  Biochem Biophys Res Commun       Date:  2006-12-11       Impact factor: 3.575

2.  Endoplasmic reticulum stress in alveolar epithelial cells is prominent in IPF: association with altered surfactant protein processing and herpesvirus infection.

Authors:  William E Lawson; Peter F Crossno; Vasiliy V Polosukhin; Juan Roldan; Dong-Sheng Cheng; Kirk B Lane; Thomas R Blackwell; Carol Xu; Cheryl Markin; Lorraine B Ware; Geraldine G Miller; James E Loyd; Timothy S Blackwell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-04-04       Impact factor: 5.464

3.  Protection from pulmonary fibrosis in leukotriene-deficient mice.

Authors:  Marc Peters-Golden; Marc Bailie; Teresa Marshall; Carol Wilke; Sem H Phan; Galen B Toews; Bethany B Moore
Journal:  Am J Respir Crit Care Med       Date:  2002-01-15       Impact factor: 21.405

4.  Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor beta.

Authors:  K Horiuchi; N Amizuka; S Takeshita; H Takamatsu; M Katsuura; H Ozawa; Y Toyama; L F Bonewald; A Kudo
Journal:  J Bone Miner Res       Date:  1999-07       Impact factor: 6.741

5.  Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation.

Authors:  Jill E Kolodsick; Marc Peters-Golden; Jose Larios; Galen B Toews; Victor J Thannickal; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2003-05-08       Impact factor: 6.914

6.  Inhalation treatment of pulmonary fibrosis by liposomal prostaglandin E2.

Authors:  Vera Ivanova; Olga B Garbuzenko; Kenneth R Reuhl; David C Reimer; Vitaly P Pozharov; Tamara Minko
Journal:  Eur J Pharm Biopharm       Date:  2012-12-08       Impact factor: 5.571

7.  Transcriptional regulation of increased CCL2 expression in pulmonary fibrosis involves nuclear factor-κB and activator protein-1.

Authors:  Xiaoling Deng; Mingyan Xu; Chao Yuan; Liqin Yin; Xihe Chen; Xiaoqiong Zhou; Guanwu Li; Yucai Fu; Carol A Feghali-Bostwick; Linhua Pang
Journal:  Int J Biochem Cell Biol       Date:  2013-04-10       Impact factor: 5.085

8.  Increased survivin expression contributes to apoptosis-resistance in IPF fibroblasts.

Authors:  Thomas H Sisson; Toby M Maher; Iyabode O Ajayi; Jessie E King; Peter D R Higgins; Adam J Booth; Rommel L Sagana; Steven K Huang; Eric S White; Bethany B Moore; Jeffrey C Horowitz
Journal:  Adv Biosci Biotechnol       Date:  2012-10

9.  Epstein-Barr virus DNA in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.

Authors:  Katerina Manika; Stella Alexiou-Daniel; Despina Papakosta; Anna Papa; Theodore Kontakiotis; Dimitrios Patakas; Antonis Antoniadis
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2007-09       Impact factor: 0.670

10.  A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis.

Authors:  Brian G Kelly; She S Lok; Philip S Hasleton; Jim J Egan; James P Stewart
Journal:  Am J Respir Crit Care Med       Date:  2002-08-15       Impact factor: 21.405
View more
  4 in total

1.  Attracting Attention: Discovery of IL-8/CXCL8 and the Birth of the Chemokine Field.

Authors:  Bethany B Moore; Steven L Kunkel
Journal:  J Immunol       Date:  2019-01-01       Impact factor: 5.422

2.  IRAK-M Regulates Monocyte Trafficking to the Lungs in Response to Bleomycin Challenge.

Authors:  Brenda F Reader; Shruthi Sethuraman; Bryan R Hay; Rose Viguna Thomas Becket; Manjula Karpurapu; Sangwoon Chung; Yong Gyu Lee; John W Christman; Megan N Ballinger
Journal:  J Immunol       Date:  2020-04-06       Impact factor: 5.422

3.  Increased expression and accumulation of GDF15 in IPF extracellular matrix contribute to fibrosis.

Authors:  Agata Radwanska; Christopher Travis Cottage; Antonio Piras; Catherine Overed-Sayer; Carina Sihlbom; Ramachandramouli Budida; Catherine Wrench; Jane Connor; Susan Monkley; Petra Hazon; Holger Schluter; Matthew J Thomas; Cory M Hogaboam; Lynne A Murray
Journal:  JCI Insight       Date:  2022-08-22

4.  Cigarette Smoke Enhances the Expression of Profibrotic Molecules in Alveolar Epithelial Cells.

Authors:  Marco Checa; James S Hagood; Rafael Velazquez-Cruz; Victor Ruiz; Carolina García-De-Alba; Claudia Rangel-Escareño; Francisco Urrea; Carina Becerril; Martha Montaño; Semiramis García-Trejo; José Cisneros Lira; Arnoldo Aquino-Gálvez; Annie Pardo; Moisés Selman
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.